CD8A and neoplasm: Local OBP-702 treatment showed significantly stronger anti-tumor effects on PAN02 tumors (Fig. 2d, e) and increased CD8 + T cells and TRMs in the tumor and TEMs in the spleen 28 days after the initial treatment (Fig. 2f–i).